Dr Wang trained in Papillomavirus VLPs at Johns Hopkins University. Prior to founding PathoVax, Joshua explored opportunities in innovation and venture creation at Flagship Ventures (now Flagship Pioneering).
Sign up to view 1 direct report
Get started